HAWTHORNE, N.J.--(BUSINESS WIRE)--Proteonomix, Inc. (OTCBB: PROT) updated the progress of its cosmeceutical business operated by its Proteoderm, Inc, subsidiary under the guidance of recently appointed CEO Jaci Mandil.
Mrs. Mandil is actively moving the company forward with plans for an anticipated third quarter launch of the Proteoderm line of anti-aging skin care products.
